RVMD
Revolution Medicines, Inc.
Revolution Medicines, Inc. (RVMD) has 10 SEC Form 4 filings (29 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Jul 1, 2026.
The most active filer is Chief Operating Officer Horn Margaret A with 3 filings. Insiders have net sold $16.4M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Mark A. Goldsmith
- Employees:883
- HQ:Redwood City, CA, US
- IPO:2020-02-13
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$16.4M
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$39.2B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Patel SushilFirst filing | Director | Sale | 5,580 | $1.0M | Jul 1 | SEC ↗ |
Horn Margaret AFirst filing | Chief Operating Officer | Sale | 60,400 | $9.7M | Jun 17 | SEC ↗ |
Horn Margaret AFirst filing | Chief Operating Officer | Sale | 3,575 | $558K | Jun 17 | SEC ↗ |
Horn Margaret AFirst filing | Chief Operating Officer | Sale | 29,600 | $4.7M | Jun 17 | SEC ↗ |
Mancini AnthonyFirst filing | See Remarks | Sale | 3,120 | $413K | Apr 29 | SEC ↗ |
Related companies
Revolution Medicines, Inc. is in the Healthcare sector.